HPV 16+ confirmed oropharynx cancer and cervical cancer

Clinical trials for HPV 16+ confirmed oropharynx cancer and cervical cancer explained in plain language.

Never miss a new study

Get alerted when new HPV 16+ confirmed oropharynx cancer and cervical cancer trials appear

Sign up with your email to follow new studies for HPV 16+ confirmed oropharynx cancer and cervical cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Experimental immune drug tested in HPV cancers – but trial halted early

Knowledge-focused Stopped early

This very early trial tested a single dose of HB-201 in 10 people with HPV 16+ throat or cervical cancer. The goal was to see how the drug affects the immune system, not to treat the cancer. The study was terminated early, so results are limited.

Matched conditions: HPV 16+ CONFIRMED OROPHARYNX CANCER AND CERVICAL CANCER

Early phase 1 • Sponsor: AstraZeneca • Aim: Knowledge-focused

Last updated Sep 16, 2026 00:00 UTC

HPV 16+ confirmed oropharynx cancer and cervical cancer

Get alerted when new HPV 16+ confirmed oropharynx cancer and cervical cancer trials appear

Experimental immune drug tested in HPV cancers – but trial halted early